20 Participants Needed

Circadian Intervention for Obesity

(TOCS Trial)

CM
Overseen ByChristopher M Depner, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial excludes people using prescription drugs or substances that affect sleep or glucose metabolism, so you may need to stop taking such medications to participate.

What data supports the effectiveness of the Circadian Intervention treatment for obesity?

Research shows that disruptions in circadian rhythms (the body's internal clock) are linked to obesity, and improving these rhythms can help regulate metabolism and energy balance. Studies suggest that aligning daily activities with natural circadian patterns may reduce obesity risk and improve sleep quality, making circadian interventions a promising approach for weight management.12345

How does the Circadian Intervention treatment for obesity differ from other treatments?

Circadian Intervention is unique because it focuses on aligning the body's internal clock (circadian rhythm) to improve metabolism and energy balance, which are often disrupted in obesity. Unlike traditional treatments that may focus on diet or exercise alone, this approach targets the timing of these activities to synchronize with the body's natural rhythms, potentially enhancing their effectiveness.13678

What is the purpose of this trial?

The overall goal is to examine the efficacy of a circadian intervention in people with overweight and obesity and habitual short sleep duration (HSSD). Participants will undergo a randomized controlled trial, with circadian intervention and control (healthy lifestyle) groups. The circadian intervention is designed to reduce nighttime light exposure and after-dinner snack food intake. Alternatively, the control group will receive basic health information (e.g., physical activity, goal setting, and nutrition when eating out).

Eligibility Criteria

This trial is for adults aged 18-45 with a BMI of 25.0-34.9 who sleep less than 6.5 hours nightly and are not currently in weight loss programs or experiencing menopause. It's not for those with significant organ diseases, diagnosed sleep disorders, psychiatric illnesses, heavy alcohol use, recent shift work history, or using drugs affecting sleep/glucose metabolism.

Inclusion Criteria

Your body mass index (BMI) is between 25.0 and 34.9.
You typically sleep less than 6.5 hours per night on average for the past 6 months.

Exclusion Criteria

You are currently participating in a weight loss or exercise program, such as the Diabetes Prevention Program.
I have a significant health condition like diabetes, heart, or kidney disease.
You drink more than 3 drinks per day or more than 14 drinks per week.
See 7 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1 night
1 overnight visit (in-person)

Baseline

Participants undergo a ~1-week ambulatory real-world monitoring segment

1 week
1 visit (in-person) at the end of the baseline

Experimental

Participants are randomized to control or intervention groups for the 8-week segment

8 weeks
1 overnight visit (in-person) at the end of the segment

Follow-up

Participants are monitored for changes in sleep and circadian measures

4 weeks

Treatment Details

Interventions

  • Circadian Intervention
Trial Overview The study tests a circadian intervention aimed at improving cardiometabolic health by reducing nighttime light exposure and after-dinner snacks versus a control group receiving basic health advice on physical activity and nutrition.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
Circadian-based intervention focused on timing of light exposure and food intake.
Group II: Control GroupActive Control1 Intervention
Provided with general health information on diet and physical activity.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Utah

Lead Sponsor

Trials
1,169
Recruited
1,623,000+

Findings from Research

Circadian rhythms play a crucial role in regulating metabolism, affecting how our bodies process energy throughout the day and night, which is important in understanding obesity.
Sleep disruptions and misalignment of our circadian rhythms are modifiable risk factors that can contribute to the development of obesity and other metabolic disorders.
The Effect of Circadian and Sleep Disruptions on Obesity Risk.Noh, J.[2020]
In a study of 41 patients with severe obesity who underwent sleeve gastrectomy, significant improvements in circadian rhythm expression were observed 9 months post-surgery, indicating more stable and less fragmented rhythms.
The recovery of circadian rhythms after weight loss was linked to better sleep quality and restored relationships between sleep patterns and circadian rhythms, which were disrupted due to obesity.
Sleeve gastrectomy in patients with severe obesity restores circadian rhythms and their relationship with sleep pattern.Barnadas Solé, C., Zerón Rugerio, MF., Foncillas Corvinos, J., et al.[2021]
Circadian rhythms play a significant role in the development of obesity and metabolic diseases, as shown by studies in mice with disrupted clock genes that exhibited metabolic dysfunctions at different sleep/wake phases.
Human studies indicate that circadian desynchrony, often seen in shift workers and those with short sleep, is linked to an increased risk of obesity, highlighting the importance of maintaining regular sleep patterns for metabolic health.
[Sleep/wake cycle, circadian disruption and the development of obesity].Masaki, T.[2012]

References

The Effect of Circadian and Sleep Disruptions on Obesity Risk. [2020]
Sleeve gastrectomy in patients with severe obesity restores circadian rhythms and their relationship with sleep pattern. [2021]
[Sleep/wake cycle, circadian disruption and the development of obesity]. [2012]
Prospective influences of circadian clocks in adipose tissue and metabolism. [2021]
Chronobiological aspects of food intake and metabolism and their relevance on energy balance and weight regulation. [2011]
[Chronobiological aspects of obesity and metabolic syndrome]. [2023]
Circadian rhythms and obesity: Timekeeping governs lipid metabolism. [2021]
Chronobiology and obesity. [2013]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security